chr11-59713211-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001005324.1(OR10V1):āc.635T>Cā(p.Leu212Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,952 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001005324.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10V1 | NM_001005324.1 | c.635T>C | p.Leu212Pro | missense_variant | 1/1 | ENST00000307552.3 | NP_001005324.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10V1 | ENST00000307552.3 | c.635T>C | p.Leu212Pro | missense_variant | 1/1 | 6 | NM_001005324.1 | ENSP00000302199.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152094Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000360 AC: 9AN: 250200Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135260
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727226
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152094Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.635T>C (p.L212P) alteration is located in exon 1 (coding exon 1) of the OR10V1 gene. This alteration results from a T to C substitution at nucleotide position 635, causing the leucine (L) at amino acid position 212 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at